
TILT Biotherapeutics has announced promising preliminary safety and efficacy data from its ongoing phase 1 clinical trial (NCT05271318) in platinum …

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …

